Kevin Slater

1.6k total citations · 1 hit paper
17 papers, 1.2k citations indexed

About

Kevin Slater is a scholar working on Molecular Biology, Spectroscopy and Biomedical Engineering. According to data from OpenAlex, Kevin Slater has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Spectroscopy and 4 papers in Biomedical Engineering. Recurrent topics in Kevin Slater's work include Advanced Proteomics Techniques and Applications (4 papers), bioluminescence and chemiluminescence research (3 papers) and 3D Printing in Biomedical Research (3 papers). Kevin Slater is often cited by papers focused on Advanced Proteomics Techniques and Applications (4 papers), bioluminescence and chemiluminescence research (3 papers) and 3D Printing in Biomedical Research (3 papers). Kevin Slater collaborates with scholars based in United Kingdom, United States and Australia. Kevin Slater's co-authors include S. P. M. Crouch, Roland Z. Kozlowski, John Fletcher, D. A. Bradbury, Kelly R. Stevens, Ken J. Rotenberg, Gustavo Carlo, Claire L. Fox, Ali Mobasheri and M. Sokal and has published in prestigious journals such as Gut, Current Opinion in Biotechnology and Drug Discovery Today.

In The Last Decade

Kevin Slater

15 papers receiving 1.2k citations

Hit Papers

The use of ATP bioluminescence as a measure of cell proli... 1993 2026 2004 2015 1993 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity
    1993 742 citations S. P. M. Crouch, Roland Z. Kozlowski et al. Journal of Immunological Methods profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin Slater United Kingdom 10 479 141 106 88 80 17 1.2k
Christopher R. Bailey United States 22 640 1.3× 128 0.9× 101 1.0× 61 0.7× 120 1.5× 63 1.5k
Mi Ae Kim South Korea 22 440 0.9× 119 0.8× 108 1.0× 133 1.5× 117 1.5× 103 1.7k
Yen‐Ting Chen Taiwan 25 541 1.1× 163 1.2× 139 1.3× 94 1.1× 90 1.1× 67 1.5k
Mengmeng Xu China 23 570 1.2× 222 1.6× 122 1.2× 108 1.2× 71 0.9× 75 1.6k
Shuang Li China 22 550 1.1× 102 0.7× 204 1.9× 103 1.2× 88 1.1× 113 1.6k
Minoru Hirano Japan 21 425 0.9× 211 1.5× 64 0.6× 79 0.9× 140 1.8× 71 1.5k
Mayumi Watanabe Japan 25 734 1.5× 72 0.5× 198 1.9× 113 1.3× 145 1.8× 138 1.9k
Tomoko Ishii Japan 19 1.0k 2.1× 144 1.0× 134 1.3× 109 1.2× 46 0.6× 44 2.6k
Clare Sansom United Kingdom 17 766 1.6× 57 0.4× 118 1.1× 119 1.4× 60 0.8× 102 1.6k
Sijun Liu China 23 741 1.5× 235 1.7× 170 1.6× 67 0.8× 49 0.6× 70 2.2k

Countries citing papers authored by Kevin Slater

Since Specialization
Citations

This map shows the geographic impact of Kevin Slater's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Slater with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Slater more than expected).

Fields of papers citing papers by Kevin Slater

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Slater. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Slater. The network helps show where Kevin Slater may publish in the future.

Co-authorship network of co-authors of Kevin Slater

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Slater. A scholar is included among the top collaborators of Kevin Slater based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Slater. Kevin Slater is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Mirkes, Evgeny M., et al.. (2014). Computational diagnosis and risk evaluation for canine lymphoma. Computers in Biology and Medicine. 53. 279–290. 5 indexed citations
2.
Mirkes, Evgeny M., et al.. (2014). Computational diagnosis of canine lymphoma. Journal of Physics Conference Series. 490. 12135–12135. 4 indexed citations
3.
Tuli, Richard, et al.. (2014). Utility of a multiple serum biomarker test to monitor remission status and relapse in dogs with lymphoma undergoing treatment with chemotherapy. Veterinary and Comparative Oncology. 15(1). 6–17. 14 indexed citations
4.
Slater, Kevin, et al.. (2013). ECM mimetic collagen I peptide and fibronectin peptide - for culture of cell types with clinical potential. Cytotherapy. 15(4). S18–S18. 1 indexed citations
5.
Eckersall, P.D., Kevin Slater, & Ali Mobasheri. (2009). Biomarkers in veterinary medicine: establishing a new international forum for veterinary biomarker research. Biomarkers. 14(8). 637–641. 5 indexed citations
6.
Ratcliffe, Lucy, Shahzad I. Mian, Kevin Slater, et al.. (2009). Proteomic identification and profiling of canine lymphoma patients*. Veterinary and Comparative Oncology. 7(2). 92–105. 15 indexed citations
7.
Ratcliffe, Lucy, Shahzad I. Mian, Kevin Slater, et al.. (2009). Proteomic identification and profiling of canine lymphoma patients. Veterinary and Comparative Oncology. 7(2). 92–105. 26 indexed citations
8.
Rotenberg, Ken J., et al.. (2005). Construction and validation of a children's interpersonal trust belief scale. British Journal of Developmental Psychology. 23(2). 271–293. 104 indexed citations
9.
Slater, Kevin. (2001). Cytotoxicity tests for high-throughput drug discovery. Current Opinion in Biotechnology. 12(1). 70–74. 100 indexed citations
10.
Cox, Anne E., et al.. (2001). Determination of the Effects of Camptothecin on Cell Cycling and Apoptosis in Human Leukaemic Cell Lines. The Scientific World JOURNAL. 1. 105–105. 1 indexed citations
11.
Slater, Kevin, et al.. (2001). Changes in Intracellular Adp:Atp Ratios as a Marker of Apoptosis. The Scientific World JOURNAL. 1. 58–58. 3 indexed citations
12.
Crouch, S. P. M. & Kevin Slater. (2001). High-throughput cytotoxicity screening: hit and miss. Drug Discovery Today. 6. 48–53. 12 indexed citations
13.
Bradbury, D. A., et al.. (2000). Measurement of the ADP:ATP ratio in human leukaemic cell lines can be used as an indicator of cell viability, necrosis and apoptosis. Journal of Immunological Methods. 240(1-2). 79–92. 148 indexed citations
14.
Crouch, S. P. M., Roland Koslowski, Kevin Slater, & Jacqueline Fletcher. (1993). The use of ATP-bioluminescence in cytokine bioassays as a measure of cell proliferation and cytotoxicity. 12(5). 397.
15.
Crouch, S. P. M., Roland Z. Kozlowski, Kevin Slater, & John Fletcher. (1993). The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. Journal of Immunological Methods. 160(1). 81–88. 742 indexed citations breakdown →
16.
Cole, A, Kevin Slater, M. Sokal, & Christopher J. Hawkey. (1993). In vivo rectal inflammatory mediator changes with radiotherapy to the pelvis.. Gut. 34(9). 1210–1214. 29 indexed citations
17.
Anderson, S. G., et al.. (1960). MURRAY VALLEY ENCEPHALITIS IN PAPUA AND NEW GUINEA: II. SEROLOGICAL SURVEY, 1956–1957. The Medical Journal of Australia. 2(11). 410–413. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher R. Bailey Breakdown of academic impact, for papers by Mi Ae Kim Breakdown of academic impact, for papers by Yen‐Ting Chen Breakdown of academic impact, for papers by Mengmeng Xu Breakdown of academic impact, for papers by Shuang Li Breakdown of academic impact, for papers by Minoru Hirano Breakdown of academic impact, for papers by Mayumi Watanabe Breakdown of academic impact, for papers by Tomoko Ishii Breakdown of academic impact, for papers by Clare Sansom Breakdown of academic impact, for papers by Sijun Liu
Rankless by CCL
2026